Xilio Therapeutics
35 hedge funds and large institutions have $24.7M invested in Xilio Therapeutics in 2024 Q4 according to their latest regulatory filings, with 9 funds opening new positions, 6 increasing their positions, 6 reducing their positions, and 5 closing their positions.
New
Increased
Maintained
Reduced
Closed
more funds holding in top 10
Funds holding in top 10: →
more capital invested
Capital invested by funds: $ → $
more first-time investments, than exits
New positions opened: | Existing positions closed:
more ownership
Funds ownership: →
6% more funds holding
Funds holding: 33 → 35 (+2)
0% more repeat investments, than reductions
Existing positions increased: 6 | Existing positions reduced: 6
Holders
35
Holding in Top 10
5
Calls
–
Puts
–
Top Buyers
| 1 | +$223K | |
| 2 | +$67.6K | |
| 3 | +$46.9K | |
| 4 |
ACA
Aptus Capital Advisors
Fairhope,
Alabama
|
+$39.2K |
| 5 |
Citadel Advisors
Miami,
Florida
|
+$38.5K |
Top Sellers
| 1 | -$497K | |
| 2 | -$35K | |
| 3 | -$25.8K | |
| 4 |
Millennium Management
New York
|
-$16.3K |
| 5 |
APP
Avantax Planning Partners
Dubuque,
Iowa
|
-$16.1K |